Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-23

Clinical Trial Update: Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the combination of faropenem and cefadroxil with amoxicillin/clavulanic acid and standard TB drugs in pulmonary tuberculosis, measuring …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amoxicillin/clavulanic acid (amoxicillin/clavulanic acid)
  • Cefadroxil (cefadroxil)
  • Faropenem (faropenem)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED